Sanofi (NASDAQ:SNY) Receives Average Recommendation of “Hold” from Analysts

Shares of Sanofi (NASDAQ:SNY) have received a consensus rating of “Hold” from the fifteen research firms that are covering the stock, Marketbeat Ratings reports. Ten research analysts have rated the stock with a hold rating, three have issued a buy rating and two have issued a strong buy rating on the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $49.50.

Several brokerages have recently weighed in on SNY. Weiss Ratings upgraded Sanofi from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, May 13th. Morgan Stanley set a $49.00 price objective on Sanofi in a research report on Wednesday. Argus upgraded Sanofi to a “strong-buy” rating in a research note on Monday, April 27th. Citigroup reissued a “neutral” rating on shares of Sanofi in a research note on Monday, April 13th. Finally, Sanford C. Bernstein upgraded shares of Sanofi to a “strong-buy” rating in a report on Thursday, March 19th.

Hedge Funds Weigh In On Sanofi

A number of institutional investors have recently modified their holdings of the stock. Flagship Harbor Advisors LLC bought a new stake in shares of Sanofi during the fourth quarter valued at approximately $25,000. Physician Wealth Advisors Inc. increased its holdings in Sanofi by 180.5% during the 1st quarter. Physician Wealth Advisors Inc. now owns 589 shares of the company’s stock worth $28,000 after purchasing an additional 379 shares during the period. Leonteq Securities AG raised its position in Sanofi by 95.8% during the 1st quarter. Leonteq Securities AG now owns 607 shares of the company’s stock valued at $29,000 after purchasing an additional 297 shares in the last quarter. Western Wealth Management LLC purchased a new stake in shares of Sanofi in the 1st quarter worth $29,000. Finally, Measured Wealth Private Client Group LLC bought a new position in shares of Sanofi during the 3rd quarter worth $29,000. 14.03% of the stock is owned by hedge funds and other institutional investors.

Sanofi Stock Down 0.5%

Shares of NASDAQ SNY opened at $42.78 on Thursday. Sanofi has a 1 year low of $40.89 and a 1 year high of $52.68. The firm has a 50-day simple moving average of $43.45 and a two-hundred day simple moving average of $45.72. The company has a market cap of $103.72 billion, a P/E ratio of 11.95, a PEG ratio of 1.09 and a beta of 0.34. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.01 and a quick ratio of 0.22.

Sanofi Increases Dividend

The business also recently disclosed an annual dividend, which was paid on Wednesday, June 3rd. Shareholders of record on Monday, May 4th were given a $2.4225 dividend. This is a positive change from Sanofi’s previous annual dividend of $2.04. The ex-dividend date of this dividend was Monday, May 4th. This represents a yield of 559.0%. Sanofi’s dividend payout ratio is presently 49.16%.

About Sanofi

Sanofi (NASDAQ:SNY) is a multinational pharmaceutical company headquartered in France that researches, develops, manufactures and markets prescription medicines, vaccines and consumer healthcare products. The company operates across multiple therapeutic areas, including immunology, rare diseases, oncology, cardiovascular and metabolic diseases, and vaccines through its Sanofi Pasteur division. Sanofi sells products to hospitals, clinics, governments and retail pharmacies, with a broad global footprint and significant presence in Europe, North America and emerging markets.

Key commercial offerings include specialty biologics and established small-molecule medicines.